The goal of this study is to investigate whether stratification of children with atopic
dermatitis on the NMF biomarkers results in an improvement of effectiveness and efficiency in
the use of systemic treatment (ciclosporin and dupilumab) in moderate-to-severe atopic
dermatitis.
Phase:
N/A
Details
Lead Sponsor:
Erasmus Medical Center
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development